Over the projected period, the market growth is predicted to be driven by the rising post-surgical utilisation opioids. For example, a meta-analysis study from the beginning to August 30, 2017, with an updated search performed on June 30, 2019, was conducted, as per an article published by JAMA Network Open Journal in June 2020, to calculate the number of people who use opioids for a longer period of time after surgery in the United States. The combined rate of people who used opioids for a long time following surgery was 6.7%, according to the findings.
The U.S. Opioids Market is estimated to be valued at US$ 16,285.2 million in 2022 and is expected to exhibit a CAGR of 5.5% during the forecast period (2022-2030).
Leading Companies in the U.S. Opioids Industry:
1. Purdue Pharmaceuticals L.P.
Purdue Pharmaceuticals L.P. was founded in 1998 is a manufacturer and market medication and consumer health products professional. The headquarters of company are situated in Wilson, North Caroline.
2. Pfizer Inc.
Pfizer Inc. since 1849 discovers. Develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The headquarters are situated in New York. Pfizer Inc. and BioTech in December, 2022 announced the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine as the third 3-µg dose in the three-dose primary series for children 6 months through 4 years of age.
3. Titan Pharmaceuticals, Inc.
The company was founded in 1992 and is based in South San Francisco, California. Titan Pharmaceuticals, Inc is a company that develops therapeutics for the treatment of chronic diseases. Titan Pharmaceuticals, Inc in the month of October, 2021 announced that it has received funding from the Bill and Melinda Gates Foundation to support the demonstration of its ability to deliver a human immunodeficiency virus preventative therapeutic and contraceptic from single implant using its proprietary ProNeura technology.
4. Assertio Holdings, Inc.
Assertio Holdings, Inc., a speciality pharmaceuticals company, provides medicines in the areas of neurology, hospital and pain and inflammation since 1995. Assertio Holdings, Inc. and BlinkRx, the leading patient access solution, in March, 2022 announced a collaboration to support healthcare professionals and their patients undergoing treatment with Otrexup.
5. Amneal Pharmaceuticals LLC
Amneal Pharmaceuticals LLC was founded in 2002 and since then developes, licenses, manufactures, markets and distributes generic and speciality pharmaceutical products. The company headquarters are situated in Bridgewater, New Jersey. Amneal Pharmaceuticals LLC in November, 2022 announced the commercial launch of RELEUKO a biosimilar referencing Neupogen RELEUKO used to treat neutropenia.
6. Trevena, Inc.
Trevena, Inc. since 2007 is a biopharmaceutical company focused on the development and commercialization of innovative medicines for patients with central nervous system (CNS) disorders. The company is headquartered in Chesterbrook, Pennsylvania.
7. Lupin
Lupin Limited was founded in 1968 and is headquartered in Mumbai, India. Lupin Limited, a pharmaceutical company, develops, produces, markets, and sells a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). The company is operational in more than 100 countries.
More than 100 countries. Lupin Limited (Lupin) in the month of December, 2022 announced the launch of authorized generic version of PENNSAID® (Diclofenac Sodium Topical Solution), 2% w/w of Horizon Pharma Therapeutics in the United States.
8. Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals Inc. was founded in 1997 and till now is pharmaceutical product manufacturing company. The company headquarters in Dublin, Ireland.
In January, 2022 Endo launched authorized generic version of Amitiza.
*Definition- Opioids are the class of drugs that include illicit drugs such as heroin, codeine, fentanyl, meperidine, methadone, morphine, hydrocodone, diphenoxylate, hydromorphone, methylphenidate, oxycodone, and oxymorphone.
